Immuneering Corporation
IMRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$59.4M | −$64.1M | +7.3% |
| Net income | −$56.0M | −$61.0M | +8.2% |
Questions
- What was Immuneering's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was Immuneering profitable in FY2025?
- No: net income was −$56.0M and operating income −$59.4M in FY2025.